🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Katie M. Campbell

University of California, Los Angeles

ORCID: 0000-0001-6491-4432
MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.0Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase

Nucleic Acids Research(2022)10.1093/nar/gkac979
Top 19%
1.0DataRank
Top 19%46 citations

Arpad Danos, Jason Saliba, Joshua F. McMichael, Adam Coffman, Susanna Kiwala +60 more

Papers

Driven by 33 papers — median percentile 0. Top paper: “Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma”.

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2020)10.1016/j.ccell.2020.08.005
N/A
9.5DataRank · unranked
393 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodríguez, Petra Ross‐Macdonald, Megan Wind‐Rotolo +31 more

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1695
N/A
7.0DataRank · unranked
368 citations

Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum +39 more

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02498-y
N/A
4.8DataRank · unranked
171 citations

Shay Bellasea, Kari Kendra, Nikhil I. Khushalani, Katie M. Campbell, Philip O. Scumpia +28 more

Non-viral precision T cell receptor replacement for personalized cell therapy

Nature(2022)10.1038/s41586-022-05531-1
N/A
4.1DataRank · unranked
281 citations

Kyle Jacoby, Daniela A. Bota, Theresa Hunter, Zheng Pan, Eric Stawiski +49 more

Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma

Cancer Cell(2023)10.1016/j.ccell.2023.03.010
N/A
2.2DataRank · unranked
82 citations

Meelad Amouzgar, Shannon M. Pfeiffer, Timothy R. Howes, Egmidio Medina, Michael J. Travers +14 more

CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase

Nucleic Acids Research(2022)10.1093/nar/gkac979
Top 19%
1.0DataRank
Top 19%46 citations

Arpad Danos, Jason Saliba, Joshua F. McMichael, Adam Coffman, Susanna Kiwala +60 more

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

Cell(2020)10.1016/j.cell.2020.09.015
N/A
0.945DataRank · unranked
543 citations

Marit M. van Buuren, Kristen K. Dang, Vanessa M. Hubbard-Lucey, Kathleen C. F. Sheehan, Katie M. Campbell +95 more

A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0145
N/A
0.752DataRank · unranked
19 citations

Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero +6 more

Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma

Science Translational Medicine(2020)10.1126/scitranslmed.abb0152
N/A
0.737DataRank · unranked
135 citations

Mito Tariveranmoshabad, Kevin Hakimi, Sarah Kremer, Katie M. Campbell, Juan M. Funes +13 more

Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity

Cell Reports(2024)10.1016/j.celrep.2024.114289
N/A
0.703DataRank · unranked
22 citations

Joo-Won Seo, Manash K. Paul, Keisuke S. Iwamoto, Allison E. Daly, An‐Chieh Feng +10 more

PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma

Nature Communications(2020)10.1038/s41467-020-19810-w
N/A
0.675DataRank · unranked
89 citations

Alain P. Algazi, Paolo A. Ascierto, Marcus O. Butler, Sunandana Chandra, Michael S. Gordon +10 more

Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.30.016931
N/A
0.593DataRank · unranked
51 citations

Gabriela Steiner, Daniel K. Wells, Antoni Ribas, Anusha Kalbasi, Katie M. Campbell

Antitumor Immune Responses in B2M -Deficient Cancers

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0139
N/A
0.546DataRank · unranked
37 citations

Mildred Galvez, Gabriel Abril-Rodríguez, Katie M. Campbell, Egmidio Medina, Agustin Vega-Crespo +4 more

Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma

Cancer Cell(2025)10.1016/j.ccell.2025.01.009
N/A
0.524DataRank · unranked
32 citations

Mouadh Benamar, Jihye Park, Haley E. Sax, Giacomo Oliveira, Alice Bosma-Moody +10 more

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial

medRxiv(2020)10.1101/2020.03.18.20037846
N/A
0.396DataRank · unranked
4 citations

Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum +39 more

Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004190
N/A
0.373DataRank · unranked
11 citations

Maneesha Thaker, Egmidio Medina, Anusha Kalbasi, Arun S. Singh, Antoni Ribas +2 more

Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1409
N/A
0DataRank · unranked
148 citations

Gabriel Abril-Rodríguez, Ameya S. Champhekar, Jennifer Tsoi, Katie M. Campbell, Anusha Kalbasi +16 more

Rigorous benchmarking of T cell receptor repertoire profiling methods for cancer RNA sequencing

medRxiv(2022)10.1101/2022.03.31.22273249
N/A
0DataRank · unranked
1 citations

Theodore S. Nowicki, Katie M. Campbell, Dandan Peng, Anish Nagareddy, Yu-Ning Huang +10 more

Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade

Cancer Research Communications(2022)10.1158/2767-9764.crc-21-0133
N/A
0DataRank · unranked
19 citations

Davis Y. Torrejon, Daniel Karin, Katie M. Campbell, Egmidio Medina, Justin D. Saco +9 more

Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer

Nature Communications(2023)10.1038/s41467-023-37266-6
N/A
0DataRank · unranked
131 citations

Yang-Yang Feng, Avinash Ramu, Megan M. Richters, Sharon L. Freshour, Zachary L. Skidmore +19 more

Evolution of the open-access CIViC knowledgebase is driven by the needs of the cancer variant interpretation community

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.13.448171
Top 100%
0DataRank
Top 100%0 citations

Arpad Danos, Susanna Kiwala, Joshua F. McMichael, Adam Coffman, Erica K. Barnell +47 more

In Silico Epitope Prediction Analyses Highlight the Potential for Distracting Antigen Immunodominance with Allogeneic Cancer Vaccines

Cancer Research Communications(2021)10.1158/2767-9764.crc-21-0029
N/A
0DataRank · unranked
4 citations

Peter Ronning, Darren R. Cullinan, Kelsy C. Cotto, Erica K. Barnell, Katie M. Campbell +8 more

Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-19-4179
N/A
0DataRank · unranked
41 citations

Katie M. Campbell, Jason A. Webb, Paul Zolkind, Zachary L. Skidmore, Rachel Riley +10 more

Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencing

Briefings in Bioinformatics(2023)10.1093/bib/bbad220
N/A
0DataRank · unranked
18 citations

Theodore S. Nowicki, Katie M. Campbell, Mohammad Vahed, Dandan Peng, Yiting Meng +13 more

Supplementary Table 5 from Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade

(2023)10.1158/2767-9764.22545378
N/A
0DataRank · unranked
0 citations

Davis Y. Torrejon, Daniel Karin, Katie M. Campbell, Egmidio Medina, Justin D. Saco +9 more

Supplementary Table S2 from A pilot study of neoadjuvant nivolumab, ipilimumab and intralesional oncolytic virotherapy for HER2-negative breast cancer

(2023)10.1158/2767-9764.23791808
Top 100%
0DataRank
Top 100%0 citations

Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero +6 more

Data from A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

(2023)10.1158/2767-9764.c.6762524
N/A
0DataRank · unranked
0 citations

Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero +6 more

An NKG2A biased immune response confers protection for infection, autoimmune disease, and cancer

Research Square(2023)10.21203/rs.3.rs-3413673/v1
N/A
0DataRank · unranked
0 citations

Daniel Chen, Jingyi Xie, Jongchan Choi, Raymond T. Ng, Rongyu Zhang +13 more

Optimizing nucleic acid extraction and transcriptome evaluation from low-input, fixed clinical samples

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.02.122150
N/A
0DataRank · unranked
0 citations

Egmidio Medina, Ignacio Baselga-Carretero, Yaroslav Teper, Rangasamy P. Elumalai, Raymond J. Miller +15 more

Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer

Cell Reports(2024)10.1016/j.celrep.2024.113872
N/A
0DataRank · unranked
12 citations

Jingyi Xie, Jongchan Choi, Raymond T. Ng, Rongyu Zhang, Sarah Li +13 more

A Spatial Omnibus Test (SPOT) for Spatial Proteomic Data

Bioinformatics(2024)10.1093/bioinformatics/btae425
N/A
0DataRank · unranked
6 citations

Katie M. Campbell, Antoni Ribas, Michael C. Wu, Sarah Samorodnitsky

A Spatial Omnibus Test (SPOT) for Spatial Proteomic Data

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.08.584117
N/A
0DataRank · unranked
3 citations

Katie M. Campbell, Antoni Ribas, Michael C. Wu, Sarah Samorodnitsky

Epigenetic Suppression of Transgenic T-cell Receptor Expression via Gamma-Retroviral Vector Methylation in Adoptive Cell Transfer Therapy

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0300
N/A
0DataRank · unranked
17 citations

Colin Farrell, Marco Morselli, Liudmilla Rubbi, Katie M. Campbell, Mignonette H. Macabali +5 more